Pharma sector boom puts pressure on compliance to counter financial crime
By 
Ruth Prickett2025-12-04T22:15:00
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Globally, the sector is booming. According to Robinson Brothers website, the global pharmaceutical industry is forecast to be worth $1.6 trillion this year. Costs are also high. It typically costs up to £1.15bn to develop and market a new treatment – which can take more than 12 years – and 95 percent of all experimental medicines studied for human treatment fail to achieve approval.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleU.K. asset managers to focus on investor engagement outcomes under new reporting guidance
Asset managers reporting under the U.K.’s updated Stewardship Code starting Jan 1 should focus on engagement outcomes and evidence of impact. New guidance from the U.K. financial regulator offers case studies and checklists to support compliance.
-
ArticleNew regulatory regimes for U.K. and EU ESG ratings firms could increase compliance costs
Environmental ratings are becoming big business as companies seek proof of sustainable and socially beneficial conduct. Firms that issue ratings on environmental, social and governance (ESG) performance are set to be regulated in the EU and U.K.
-
ArticleU.K. Cyber Security and Resilience bill set to regulate critical infrastructure suppliers
Suppliers to the U.K. critical infrastructure will face new regulations to ensure they are protected from cyberattacks. The Cyber Security and Resilience Bill, introduced on November 12, also raises penalties for breaches and expands regulator powers to label certain suppliers as critical.
More from Regulatory Policy
-
ArticleU.K. listed companies must adapt to new sustainability reporting regime by 2027
Sustainability reporting rules for U.K. listed companies are set to change. The U.K. financial regulator has launched a consultation laying out its proposals, which aim to align the reporting regime with the international ISSB standards.
-
ArticleU.K. ‘buy now pay later’ regulation signals end of ‘Wild West’ fintech loans system
Firms offering “buy now, pay later” financing will become part of the regulated financial services sector in the U.K. from July 15. Compliance teams must act now to ensure they are ready to introduce rules and establish creditworthiness assessment processes, adapt systems, and change data processes before the deadline.
-
ArticleNew EU rules will force companies to come clean on pay
New rules that will be introduced this June will require companies based in the European Union (EU) to explain why some workers are paid more money for the same job and remedy any “unjustified” discrepancies.